SynthesisEndocrine, metabolic & immune disorders drug targets2026
From Mechanism to Therapy: Isoliquiritigenin as a Novel Anti-Inflammatory Agent for Inflammatory Disease Management
Fangfang Qi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.